Blood disorders and treatments
Blood disorders and treatments is a research topic within Genetics. Science Explorer counts 23k research works in it since 1950. 11.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the genetic basis and clinical manifestations of various neutropenia disorders, including Shwachman-Diamond syndrome, Kostmann disease, and Cohen syndrome. It explores the impact of mutations in genes such as ELANE, HAX1, GFI1, and SBDS on neutrophil development and function, as well as the implications for hematopoietic stem cell transplantation and G-CSF therapy. The research also delves into the molecular mechanisms underlying neutropenia and potential therapeutic targets.
- Neutropenia
- Genetic Mutations
- Congenital Disorders
- G-CSF Therapy
- ELANE Gene
- Hematopoietic Stem Cells
- Shwachman-Diamond Syndrome
- HAX1 Deficiency
- Gfi1 Transcription Factor
- SBDS Gene
- Research works
- 23k fractional, since 1950
- In the world top 10%
- 2.6k per year above
- Top-10% rate
- 11.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +25% the tick is no change
Which countries lead Blood disorders and treatments research?
By volume, the United States and China publish the most (749 and 315 works in 2022–2025).
By volume, 2022–2025
- 1 United States 749 works
- 2 China 315 works
- 3 India 193 works
- 4 Japan 153 works
- 5 Germany 149 works
- 6 France 117 works
- 7 Italy 111 works
- 8 United Kingdom 103 works
- 9 Brazil 93 works
- 10 Spain 88 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Blood disorders and treatments research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Blood disorders and treatments research, followed by Cleveland Clinic and The University of Texas MD Anderson Cancer Center.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 12 works
- 2 Cleveland ClinicUnited States 11 works
- 3 The University of Texas MD Anderson Cancer CenterUnited States 10 works
- 4 Harvard UniversityUnited States 10 works
- 5 InsermFrance 10 works
- 6 All India Institute of Medical SciencesIndia 9 works
- 7 Post Graduate Institute of Medical Education and ResearchIndia 9 works
- 8 University of WashingtonUnited States 8 works
- 9 Washington University in St. LouisUnited States 8 works
- 10 Yale UniversityUnited States 8 works
Who are the leading researchers in Blood disorders and treatments?
The most-cited researchers publishing on Blood disorders and treatments include Winfried März, Hagop M. Kantarjian and Thomas Schwarz.
- 1 Winfried März Germany 5.2k citations
- 2 Hagop M. Kantarjian United States 4k citations
- 3 Thomas Schwarz United States 3.1k citations
- 4 Jean‐Louis Vincent Belgium 3.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Blood disorders and treatments research done?
The largest centres of Blood disorders and treatments research in 2022–2025 are Paris (France), Beijing (China), New York (United States) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Bethesda.
Largest cities, 2022–2025
Where it is the local speciality
- BethesdaUS · 23.1 works6.4×
Location quotient: how much more of its research is in Blood disorders and treatments than the world average.
Where is the best place to study Blood disorders and treatments?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Harvard University and Post Graduate Institute of Medical Education and Research score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 48.9 | 11.3% | 4.4× | 12 | +30.5% |
| 2 | Harvard UniversityUnited States | 47.2 | 20.2% | 2.7× | 10 | +15.6% |
| 3 | Post Graduate Institute of Medical Education and ResearchIndia | 46.3 | 4.8% | 8.9× | 8 | +78.8% |
| 4 | University of WashingtonUnited States | 13.5 | 6.7% | 2.8× | 8 | -4.6% |
| 5 | All India Institute of Medical SciencesIndia | 13.3 | 1.3% | 4.9× | 9 | -6.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Blood disorders and treatments research growing?
Output in 2018–2022 was 25% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Blood disorders and treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.